Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
« Previous Article | Table of Contents
Arteriosclerosis, Thrombosis, and Vascular Biology. 1986;6:237-241

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugano, M.
Right arrow Articles by Koide, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugano, M.
Right arrow Articles by Koide, O.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*CHOLESTEROL
*DILTIAZEM
Medline Plus Health Information
*Dietary Fats

Arteriosclerosis, Vol 6, 237-241, Copyright © 1986 by American Heart Association

ARTICLES

Suppression of atherosclerosis in cholesterol-fed rabbits by diltiazem injection

M Sugano, Y Nakashima, T Matsushima, K Takahara, M Takasugi, A Kuroiwa and O Koide

The effects of diltiazem, a calcium antagonist, on the development of atherosclerosis were studied in Japanese white rabbits. The rabbits were examined at the end of 10 weeks on the following regimens; a diet of standard pellets and daily intraperitoneal (ip) injections of saline; a diet of pellets containing 1% cholesterol and daily ip injections of saline; or a diet of pellets containing 1% cholesterol and daily ip injections of diltiazem (50 mg). The plasma total and LDL cholesterol levels for the third group were significantly lower than those of the cholesterol diet group. Macroscopically, atheromatous lesions covered 26.7% +/- 6.7% (mean +/- SE) of the intimal surface of the aorta in the second group, and 0.7% +/- 0.3% in the third group (p less than 0.005). The levels of cholesterol, calcium, and uronic acid in the aortic tissue of the second group were significantly higher than those in the third. We concluded that diltiazem administered intraperitoneally suppresses the plasma total and LDL cholesterol elevation induced by the cholesterol diet and inhibits experimentally- induced atherosclerosis.


This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
M. Sugano, N. Makino, S. Sawada, S. Otsuka, M. Watanabe, H. Okamoto, M. Kamada, and A. Mizushima
Effect of Antisense Oligonucleotides against Cholesteryl Ester Transfer Protein on the Development of Atherosclerosis in Cholesterol-fed Rabbits
J. Biol. Chem., February 27, 1998; 273(9): 5033 - 5036.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
A. Miyazaki, S. Sakuma, W. Morikawa, T. Takiue, F. Miake, T. Terano, M. Sakai, H. Hakamata, Y.-I. Sakamoto, M. Naito, et al.
Intravenous Injection of Rabbit Apolipoprotein A-I Inhibits the Progression of Atherosclerosis in Cholesterol-Fed Rabbits
Arterioscler Thromb Vasc Biol, November 1, 1995; 15(11): 1882 - 1888.
[Abstract] [Full Text]

Home page
 NEJMHome page
J. S. Schroeder, S.-Z. Gao, E. L. Alderman, S. A. Hunt, I. Johnstone, D. B. Boothroyd, V. Wiederhold, and E. B. Stinson
A Preliminary Study of Diltiazem in the Prevention of Coronary Artery Disease in Heart-Transplant Recipients
N. Engl. J. Med., January 21, 1993; 328(3): 164 - 170.
[Abstract] [Full Text]

Home page
 ANGIOLOGYHome page
R. Gasser
Calcium Antagonists: Pharmacologic Agents in Search of New Clinical Indications
Angiology, January 1, 1990; 41(1): 36 - 43.
[Abstract] [PDF]


ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search
Copyright © 1986 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited.